2024 NHLBI Workshop Charts Promising Future Directions for ECMO-Induced Coagulopathy
Jerrold Levy, MD, Critical care physician in CTICU, Duke University School of Medicine, recently shared an insightful post on X:
”ECMO-induced coagulopathy: strategic initiatives for research and clinical practice (workshop NHLBI report). This open access 2024 summary is online and new ASH journal (BLOODVTH) not on PubMED yet. Extracorporeal Life Support Organization (ELSO) please share with your community.”
Read the full article here.
The NHLBI hosted a May 2024 workshop on ECMO-induced coagulopathy, uniting experts to tackle anticoagulation challenges and advance precision medicine approaches.
The event highlighted research gaps, innovative therapies, and opportunities for interdisciplinary collaboration to improve patient outcomes.
More news on scientific advancements in Hemostasis Today.
-
Mar 6, 2026, 09:15Reza Bavarsad Shahripour: When the Ophthalmic Artery Tells the Story of the Carotid
-
Mar 6, 2026, 09:13Louise St. Germain Bannon: Advancing Thrombosis and Hemostasis Through a Global Community
-
Mar 6, 2026, 09:06Kathleen Freson: Protein C Deficiency as a Genetic Modifier of Severe Haemophilia A
-
Mar 5, 2026, 17:48Estelle Carminita։ What If the Origin of Platelet Dysfunction Starts in the Bone Marrow
-
Mar 5, 2026, 17:43Pierre Sabouret: The Best Antithrombotic Strategy in Patients with Atherosclerotic Stroke and AF
-
Mar 5, 2026, 17:37John Abraham։ The Role of Diagnostic Splenectomy in Unexplained Splenomegaly
-
Mar 5, 2026, 17:31Fayad Al-Haimus: Key Themes from the New 2026 AHA/ACC Guideline for Acute PE
-
Mar 5, 2026, 16:56From Chronic Pain with Every Step to Exercising Every Day – EHC
-
Mar 5, 2026, 15:51Samer Al Hadidi: Cytopenias and Infection Risk With BCMA-Directed Bispecific Antibodies